X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
84
PharmaCompass offers a list of Gabapentin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gabapentin manufacturer or Gabapentin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gabapentin manufacturer or Gabapentin supplier.
PharmaCompass also assists you with knowing the Gabapentin API Price utilized in the formulation of products. Gabapentin API Price is not always fixed or binding as the Gabapentin Price is obtained through a variety of data sources. The Gabapentin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gabapentin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gabapentin, including repackagers and relabelers. The FDA regulates Gabapentin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gabapentin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
CLICK HERE to find a list of Gabapentin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gabapentin supplier is an individual or a company that provides Gabapentin active pharmaceutical ingredient (API) or Gabapentin finished formulations upon request. The Gabapentin suppliers may include Gabapentin API manufacturers, exporters, distributors and traders.
CLICK HERE to find a list of Gabapentin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gabapentin DMF (Drug Master File) is a document detailing the whole manufacturing process of Gabapentin active pharmaceutical ingredient (API) in detail. Different forms of Gabapentin DMFs exist exist since differing nations have different regulations, such as Gabapentin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gabapentin DMF submitted to regulatory agencies in the US is known as a USDMF. Gabapentin USDMF includes data on Gabapentin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gabapentin USDMF is kept confidential to protect the manufacturer’s intellectual property.
CLICK HERE to find a list of Gabapentin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Gabapentin Drug Master File in Japan (Gabapentin JDMF) empowers Gabapentin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Gabapentin JDMF during the approval evaluation for pharmaceutical products. At the time of Gabapentin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
CLICK HERE to find a list of Gabapentin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Gabapentin Drug Master File in Korea (Gabapentin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Gabapentin. The MFDS reviews the Gabapentin KDMF as part of the drug registration process and uses the information provided in the Gabapentin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Gabapentin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Gabapentin API can apply through the Korea Drug Master File (KDMF).
CLICK HERE to find a list of Gabapentin suppliers with KDMF on PharmaCompass.
A Gabapentin CEP of the European Pharmacopoeia monograph is often referred to as a Gabapentin Certificate of Suitability (COS). The purpose of a Gabapentin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gabapentin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gabapentin to their clients by showing that a Gabapentin CEP has been issued for it. The manufacturer submits a Gabapentin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gabapentin CEP holder for the record. Additionally, the data presented in the Gabapentin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gabapentin DMF.
A Gabapentin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gabapentin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
CLICK HERE to find a list of Gabapentin suppliers with CEP (COS) on PharmaCompass.
A Gabapentin written confirmation (Gabapentin WC) is an official document issued by a regulatory agency to a Gabapentin manufacturer, verifying that the manufacturing facility of a Gabapentin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Gabapentin APIs or Gabapentin finished pharmaceutical products to another nation, regulatory agencies frequently require a Gabapentin WC (written confirmation) as part of the regulatory process.
CLICK HERE to find a list of Gabapentin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gabapentin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gabapentin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gabapentin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gabapentin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gabapentin NDC to their finished compounded human drug products, they may choose to do so.
CLICK HERE to find a list of Gabapentin suppliers with NDC on PharmaCompass.
Gabapentin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gabapentin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gabapentin GMP manufacturer or Gabapentin GMP API supplier for your needs.
A Gabapentin CoA (Certificate of Analysis) is a formal document that attests to Gabapentin's compliance with Gabapentin specifications and serves as a tool for batch-level quality control.
Gabapentin CoA mostly includes findings from lab analyses of a specific batch. For each Gabapentin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gabapentin may be tested according to a variety of international standards, such as European Pharmacopoeia (Gabapentin EP), Gabapentin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gabapentin USP).
Market Place
